Center of Oncology, University Medical Center Hamburg-Eppendorf, Germany.
Radiother Oncol. 2012 Mar;102(3):466-71. doi: 10.1016/j.radonc.2012.01.005. Epub 2012 Feb 11.
Replication-dependent radiosensitization of tumors ranks among the most promising tools for future improvements in tumor therapy. However, cell cycle checkpoint signaling during S phase is a key for maintaining genomic stability after ionizing irradiation allowing DNA damage repair by stabilizing replication forks, inhibiting new origin firing and recruiting DNA repair proteins. As the impact of the different types of DNA damage induced by ionizing radiation on replication fork functionality has not been investigated, this study was performed in tumor cells treated with various agents that induce specific DNA lesions.
U2OS cells were exposed to methyl methanesulfonate (MMS) to induce base damage, low or high concentrations of hydrogen peroxide for the induction of SSBs, Topotecan to induce DSBs at replication, Mitomycin C (MMC) to induce interstrand cross-links or ionizing irradiation to analyze all damages. Chk1 phosphorylation, origin firing and replication fork progression, and cell cycle distribution were analyzed.
In our system, the extent of Chk1 phosphorylation was dependent on the type of damage induced and prolonged Chk1 phosphorylation correlated with the inhibition of replication initiation. Ionizing radiation, high concentrations of hydrogen peroxide, and Topotecan affected replication elongation much more strongly that the other agents. Almost all agents induced a slight increase in the S phase population but subsequent G2 arrest was only observed in response to those agents that strongly inhibited replication elongation and caused prolonged Chk1 phosphorylation.
Our data suggest that to improve radiotherapy, radiosensitivity in S phase could be increased by combining irradiation with agents that induce secondary DSB or inhibit checkpoint signaling, such as inhibitors of PARP or Chk1.
肿瘤的复制依赖性放射增敏作用是未来提高肿瘤治疗效果的最有前途的工具之一。然而,S 期细胞周期检查点信号转导是维持基因组稳定性的关键,它可以通过稳定复制叉、抑制新起点的启动以及募集 DNA 修复蛋白来实现电离辐射引起的 DNA 损伤修复。由于尚未研究电离辐射引起的不同类型的 DNA 损伤对复制叉功能的影响,因此本研究在使用各种诱导特定 DNA 损伤的药物处理的肿瘤细胞中进行。
用甲基甲磺酸(MMS)处理 U2OS 细胞以诱导碱基损伤,用低浓度或高浓度的过氧化氢诱导 SSB,用拓扑替康在复制时诱导 DSB,用丝裂霉素 C(MMC)诱导链间交联或电离辐射来分析所有损伤。分析 Chk1 磷酸化、起点启动和复制叉进展以及细胞周期分布。
在我们的系统中,Chk1 磷酸化的程度取决于诱导的损伤类型,并延长 Chk1 磷酸化与复制起始的抑制相关。电离辐射、高浓度的过氧化氢和拓扑替康对复制延伸的影响比其他药物要强得多。几乎所有的药物都导致 S 期细胞群略有增加,但随后的 G2 期阻滞仅在那些强烈抑制复制延伸并导致 Chk1 磷酸化延长的药物中观察到。
我们的数据表明,为了提高放射治疗效果,可以通过将照射与诱导二次 DSB 或抑制检查点信号的药物(如 PARP 或 Chk1 抑制剂)联合使用来增加 S 期的放射敏感性。